Total planned funding: $721,245,476
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $136,115,527 |
Tanzania | $97,236,049 |
Kenya | $92,592,315 |
South Africa | $72,440,125 |
Ethiopia | $57,242,381 |
Zambia | $40,915,379 |
Nigeria | $39,357,246 |
Botswana | $23,957,033 |
Namibia | $20,384,534 |
Côte d'Ivoire | $19,111,681 |
Rwanda | $17,699,085 |
Malawi | $17,140,623 |
Democratic Republic of the Congo | $15,519,195 |
Uganda | $13,458,948 |
Eswatini | $11,804,865 |
Lesotho | $6,992,197 |
India | $6,240,217 |
Caribbean Region | $4,662,200 |
South Sudan | $3,792,945 |
Angola | $3,598,636 |
Haiti | $3,465,500 |
Central Asia Region | $3,163,000 |
Vietnam | $3,131,997 |
Zimbabwe | $3,035,500 |
Central America Region | $2,903,298 |
Ukraine | $1,900,000 |
Burma | $1,300,000 |
Guyana | $785,000 |
Ghana | $650,000 |
Burundi | $600,000 |
China | $50,000 |
Organizational Types
University | $721,245,476 |
Program Areas
Treatment | $298,747,494 |
Prevention | $132,751,910 |
Governance and Systems | $123,975,562 |
Care | $106,764,723 |
Testing | $59,005,788 |
Budget Codes
HTXS: Treatment: Adult Treatment | $258,844,710 |
HVCT: Testing: HIV Testing and Counseling | $59,005,788 |
HVSI: Strategic Information | $58,056,390 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $50,433,639 |
OHSS: Health Systems Strengthening | $48,237,367 |
HBHC: Care: Adult Care and Support | $46,804,103 |
HVOP: Sexual Prevention: Other Sexual Prevention | $38,044,805 |
PDTX: Treatment: Pediatric Treatment | $35,778,521 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $32,916,747 |
HVTB: Care: TB/HIV | $31,891,660 |
HLAB: Laboratory Infrastructure | $17,681,805 |
HKID: Care: Orphans and Vulnerable Children | $14,121,700 |
PDCS: Care: Pediatric Care and Support | $13,947,260 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,202,162 |
HTXD: Treatment: ARV Drugs | $4,124,263 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,056,956 |
HMIN: Biomedical Prevention: Injection Safety | $1,423,438 |
HMBL: Biomedical Prevention: Blood Safety | $674,163 |